Results 11 to 20 of about 4,375,182 (366)

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

open access: yesHaematologica, 2013
The optimal post-remission treatment for acute myeloid leukemia in first complete remission remains uncertain. Previous comparisons of autologous versus allogeneic hematopoietic cell transplantation noted higher relapse, but lower treatment-related ...
Armand Keating   +18 more
doaj   +2 more sources

Injection of Autologous Blood versus Corticosteroid for Lateral Epicondylitis: A Randomised Controlled Study

open access: yesJournal of Orthopaedic Surgery, 2014
Purpose. To compare the efficacy of autologous blood injection versus corticosteroid injection for lateral epicondylitis. Methods. 21 men and 59 women (mean age, 45.2 years) presenting with lateral epicondylitis were randomised to receive either ...
Hasan Onur Arik   +5 more
doaj   +2 more sources

Efficacy of autologous fibrin glue versus sutures for conjunctival autograft in pterygium surgery: A 1-year randomized controlled study

open access: yesJournal of Clinical Ophthalmology and Research, 2020
Background and Aim: In recent times, the use of fibrin glue has reduced operating time and postoperative complications associated with sutures. Since it is a plasma-derived product, it has few drawbacks.
B K Rekha, Sheetal V Girimallanavar
doaj   +1 more source

Autologous blood transfusion

open access: bronzePlastic and Reconstructive Surgery, 1990
Norig Ellison
openaire   +3 more sources

Comparison of the efficacy of local autologous blood and corticosteroid injection on pain and function in patients with Tennis elbow [PDF]

open access: yesCaspian Journal of Internal Medicine, 2023
Background: Tennis elbow or lateral epicondylitis is a common complaint involving about a 3-5% cases in a community. Non-surgical treatment is effective in 80% of cases.
Rahmatollah Jokar   +5 more
doaj  

Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

open access: yesCells, 2022
The infusion of autograft immune effector cells directly impacts the clinical outcomes of patients treated with autologous peripheral blood hematopoietic stem cell transplantation, suggesting the possibility of an autologous graft-versus tumor cells ...
Luis F. Porrata
doaj   +1 more source

Transfusion of autologous blood

open access: yesMedicina, 2008
Recently the use of allogeneic (donor) blood transfusion is widely accepted in the clinical practice. Despite of good quality and safety of preparation of allogeneic blood, there are some risks related with transfusion: hemolytic, febrile, and allergic reactions, transfusion related acute lung injury, negative immunomodulatory effect, transmission of ...
Veikutienė, Audronė   +2 more
openaire   +3 more sources

Treatment of Lateral Epicondylitis With Autologous Blood, Platelet-Rich Plasma, or Corticosteroid Injections: A Systematic Review of Overlapping Meta-analyses

open access: yesOrthopaedic Journal of Sports Medicine, 2019
Background: Previous meta-analyses have been conducted to compare outcomes of various treatment injections for lateral epicondylitis (LE), including corticosteroid injection (CSI) and autologous blood products such as autologous blood (AB) and platelet ...
Darby A. Houck   +4 more
semanticscholar   +1 more source

Complications and Recurrence after Pterygium Excision using Mitomycin C Eye Drops versus Sutureless and Glue Free Conjunctival Autograft: A Prospective Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Recurrence is the most common problem with pterygium excision. Various adjunctive methods have been described to decrease the recurrence rate of pterygium. Mitomycin C (MMC) and limbal Conjunctival Autograft (CAG) are most commonly used
Prachi Shukla, Suman Bhartiya
doaj   +1 more source

A survey on cellular and engineered tissue therapies in Europe in 2008 [PDF]

open access: yes, 2010
Cellular therapy is an evolving investigational treatment modality in regenerative medicine, but little published information is available on its current use.
Baldomero, Helen   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy